IDHQ stock forecast, quote, news & analysis

Key Takeaways

• IDHQ tracks the S&P Quality Developed ex-U.S. LargeMidCap Index, selecting international developed-market stocks with the highest quality scores based on return on equity, accruals ratio, and financial leverage.
• The ETF holds approximately 200 securities with a competitive 0.29% expense ratio and carries a Morningstar Gold Medalist Rating.
• Industrials (roughly 28%) and Technology (roughly 18%) dominate sector exposure, with top holdings including ASML, Roche, SK hynix, and Novartis.
• The portfolio's quality factor methodology has provided resilience during periods of global economic uncertainty, favoring companies with strong balance sheets and consistent profitability.
• Key risks include concentration in semiconductor and industrial cyclicals, foreign currency fluctuations, and sensitivity to global trade policy developments.

Invesco S&P International Developed Quality ETF (IDHQ) Overview

The Invesco S&P International Developed Quality ETF is a passively managed fund that seeks to track the S&P Quality Developed ex-U.S. LargeMidCap Index. The underlying index selects constituents from the broader S&P Developed ex-U.S. LargeMidCap universe and ranks them by a composite quality score derived from three fundamental metrics: return on equity, accruals ratio, and financial leverage ratio. The result is a concentrated portfolio of approximately 200 international developed-market companies that demonstrate superior financial discipline and profitability relative to peers.

With an expense ratio of 0.29% and assets under management (AUM) of roughly $837 million, IDHQ offers cost-efficient access to a quality-factor strategy. The portfolio is rebalanced and reconstituted semi-annually. Top holdings include ASML Holding N.V., Roche Holding AG, SK hynix Inc., Novartis AG, Allianz SE, Advantest Corporation, Rolls-Royce Holdings plc, Safran SA, and Tokyo Electron Ltd. Geographically, Japan represents the largest country weight at approximately 19%, followed by the United Kingdom (12.5%), Switzerland (11.8%), Germany (7.5%), and France (6.7%).

Industry and Thematic Landscape

IDHQ operates at the intersection of two powerful investment themes: the quality factor premium and international developed-market equity exposure. The quality factor has historically demonstrated an ability to deliver excess returns over full market cycles by favoring companies with durable competitive advantages, high profitability, and conservative balance sheets. In the current macroeconomic environment—characterized by moderating but still-elevated interest rates, persistent geopolitical uncertainty, and uneven global growth—quality-oriented strategies have attracted sustained investor interest.

The ETF's heavy tilt toward industrials and technology places it squarely within several structural growth narratives. Global semiconductor demand continues to expand, driven by artificial intelligence infrastructure buildouts, cloud computing, and automotive electrification. European aerospace and defense companies have benefited from increased government defense spending across NATO member states. Meanwhile, the industrial automation and electrification themes—represented by holdings such as ABB Ltd and Siemens Energy—remain supported by long-term decarbonization and efficiency trends. On the healthcare side, pharmaceutical giants like Roche and Novartis provide defensive characteristics and steady cash flow generation.

Currency dynamics also play a meaningful role. A weakening U.S. dollar tends to boost returns for U.S.-based investors holding unhedged international equity exposure, while dollar strength creates a headwind. Monetary policy divergence between the Federal Reserve and other major central banks—particularly the European Central Bank and the Bank of Japan—remains a key variable influencing relative currency movements.

Performance and Positioning Snapshot

IDHQ has exhibited a broadly constructive trend in recent months, supported by strength across its largest sector exposures. The portfolio's substantial weighting in semiconductor-related names—including ASML, SK hynix, Advantest, and Tokyo Electron—has been a significant performance contributor, as global chip demand remains structurally elevated. ASML, the Dutch lithography leader and typically the fund's largest holding, continues to benefit from its near-monopoly position in extreme ultraviolet (EUV) lithography equipment essential for advanced chip manufacturing.

Industrial holdings have also provided tailwinds. Rolls-Royce Holdings has sustained its multi-year operational turnaround, while Safran and Airbus have capitalized on robust civil aerospace demand and recovering wide-body aircraft production rates. European insurers such as Allianz and Zurich Insurance Group have benefited from higher interest rates, which improve the yield on their substantial fixed-income investment portfolios.

The fund's quality screen has helped mitigate downside during risk-off episodes by underweighting companies with weaker balance sheets or less consistent earnings profiles. However, the portfolio's concentration in cyclical sectors means it remains sensitive to global growth expectations and trade policy developments. The approximately 5.8% allocation to South Korea—primarily through SK hynix—introduces exposure to geopolitical dynamics on the Korean Peninsula and semiconductor supply chain considerations.

AI Screener

For investors seeking to complement broad ETF analysis with targeted stock-level discovery, Tickeron's AI Screener offers an AI-powered platform that scans thousands of securities using technical indicators, fundamental metrics, volatility measures, and AI-generated trading signals. The screener enables users to filter by industry, market capitalization, price patterns, and performance characteristics, helping identify trending securities, breakout candidates, and new opportunities more efficiently than manual screening. Whether researching individual holdings within international quality ETFs or exploring entirely new investment themes, the AI Screener provides a data-driven starting point for deeper analysis.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape IDHQ's trajectory through the remainder of 2026. Global central bank policy remains the most consequential macro variable. If the Federal Reserve maintains a cautious easing stance while European and Japanese central banks proceed with gradual normalization, currency crosscurrents could meaningfully impact dollar-denominated returns. A sustained period of dollar weakness would provide a tailwind for unhedged international equity exposure.

The semiconductor cycle warrants close attention given the fund's significant technology exposure. While AI-related demand shows no signs of abating, the sector is historically cyclical, and any slowdown in hyperscaler capital expenditure or shifts in export control regimes could affect key holdings. Trade policy developments—particularly between the U.S., China, and the European Union—represent an ongoing risk for internationally focused portfolios.

On the industrial side, European defense spending commitments and aerospace production ramp-up schedules will influence performance for companies like Safran, Airbus, and Rolls-Royce. The healthcare holdings provide a partial buffer against cyclical volatility, though pharmaceutical pricing reforms and patent cliffs remain sector-specific risks. Finally, ETF flow dynamics and institutional positioning in international developed-market strategies will offer insight into whether the quality factor continues to attract capital in an environment where valuations in certain U.S. equity segments appear stretched relative to international counterparts.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations